Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Per Karlsson

Professor/ chief physician

Per Karlsson
Professor/ chief physician
per.karlsson@oncology.gu.se
+46 31-342 1000

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Blå stråket 2 su/jubileusklin , 41345 Göteborg


Department of Oncology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313428503
Visiting Address: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

About Per Karlsson

Head of the Department of Oncology

Latest publications

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Martin Sjöström, S Laura Chang, Nick Fishbane, Elai Davicioni, Shuang G Zhao et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2019
Journal article

Integration of biological factors in the treatment plan evaluation in breast cancer radiotherapy
Henrik Svensson, Dan Lundstedt, Maria Hällje, Magnus Gustafsson, Roumiana Chakarova et al.
Physics and Imaging in Radiation Oncology, Journal article 2019
Journal article

Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes.
Jamila Adra, Dan Lundstedt, Fredrika Killander, Erik Holmberg, Mahnaz Haghanegi et al.
International journal of radiation oncology, biology, physics, Journal article 2019
Journal article

---Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy.
Martin Sjöström, S Laura Chang, Nick Fishbane, Elai Davicioni, Linda Hartman et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2019
Journal article

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial.
Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, Erik Holmberg, Linda Hartman et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2019
Journal article

Showing 81 - 90 of 110

2010

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Christoph Engel, Beatrix Versmold, Barbara Wappenschmidt, Jacques Simard, Douglas F Easton et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Journal article 2010
Journal article

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Antonis C Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M Sinilnikova, Sue Healey et al.
Cancer research, Journal article 2010
Journal article

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
Logan C Walker, Zachary S Fredericksen, Xianshu Wang, Robert Tarrell, Vernon S Pankratz et al.
Breast cancer research : BCR, Journal article 2010
Journal article

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
Toshima Z Parris, Anna Danielsson, Szilard Nemes, Anikó Kovács, Ulla Delle et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2010
Journal article

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.
Mats Lambe, Annette Wigertz, Marit Holmqvist, Jan Adolfsson, Carola Bardage et al.
Breast cancer research and treatment, Journal article 2010
Journal article

Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial.
Dan Lundstedt, Magnus Gustafsson, Per Malmström, Karl-Axel Johansson, David Alsadius et al.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Journal article 2010
Journal article

2009

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
Viale, Giobbie-Hurder, Gusterson, Maiorano, Mastropasqua et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Journal article 2009
Journal article

Showing 81 - 90 of 110

Page Manager: Katarina Olinder Eriksson|Last update: 3/28/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?